GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MEDITERA TIBBI MALZEME SANAYI VE TICARET AS (IST:MEDTR) » Definitions » EPS (Basic)

MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) EPS (Basic) : ₺-0.10 (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS EPS (Basic)?

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₺-0.59. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₺-0.10.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's EPS (Diluted) for the three months ended in Mar. 2025 was ₺-0.59. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₺-0.10.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's EPS without NRI for the three months ended in Mar. 2025 was ₺-0.53. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.01.

During the past 12 months, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's average EPS without NRIGrowth Rate was -94.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was -18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's highest 3-Year average EPS without NRI Growth Rate was 135.50% per year. The lowest was -18.90% per year. And the median was 101.50% per year.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS EPS (Basic) Historical Data

The historical data trend for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS EPS (Basic) Chart

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
Get a 7-Day Free Trial 0.51 1.41 0.96 0.31 0.62

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.23 0.15 0.11 -0.59

MEDITERA TIBBI MALZEMENAYI VE TICARET AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(73.43-0)/119.000
=0.62

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-69.995-0)/119.000
=-0.59

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS  (IST:MEDTR) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS EPS (Basic) Related Terms

Thank you for viewing the detailed overview of MEDITERA TIBBI MALZEMENAYI VE TICARET AS's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Traded in Other Exchanges
N/A
Address
Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Headlines

No Headlines